HALO (HALOZYME THERAPEUTICS INC) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold HALO (HALOZYME THERAPEUTICS INC) with a combined value of $963.34M across 14,314,045 shares. The largest holder is BlackRock, Inc. with a position worth $885.25M (0.01% of their portfolio). 2 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$963.34M
Total Shares Held
14,314,045
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $885.25M | 0.01% | +2.3% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $37.87M | 0.06% | -43.7% |
| 3 | Bridgewater Associates, LP | $37.79M | 0.14% | +15.3% |
| 4 | CITADEL ADVISORS LLC | $2.42M | 0.00% | -89.3% |